Publications
- Pembrolizumab in pretreated patient2018 | Faculty of Medicine in Hradec Králové
- Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy2017 | First Faculty of Medicine, Central Library of Charles University
- Immunoterapy related toxicities2017 | Faculty of Medicine in Hradec Králové
- Immune-related adverse events2017 | Faculty of Medicine in Hradec Králové
- Adverse Effects of Modern Treatment of Malignant Melanoma and their Treatment/Management2014 | Faculty of Medicine in Hradec Králové
- Tamoxifen and arrhythmia2010 | Faculty of Medicine in Hradec Králové
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...